GHIT Fund Global Health Innovative Technology Fund

We seek out R&D solutions to health where others don’t

We catalyze creative partnerships across different sectors and cultures

We believe medicine is invaluable with access, valueless without it

Health is a right, not an option

Scroll

The Japan-based GHIT Fund is an international public-private partnership fund for global health R&D
that mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics
for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.

LATEST NEWS

November 19, 2019 | Tools

GHIT Fund Leaflet

November 15, 2019 | News

New investment opportunity for Product Development Platform

November 15, 2019 | News

New investment opportunity for Target Research Platform

October 18, 2019 | Events

Register now! GHIT R&D Forum 2019

September 30, 2019 | Press Release

GHIT Fund Announces New Investments: A Total of 630 Million Yen in Drug for M…

September 27, 2019 | Events

Event Report: TICAD7 “An Africa free from Neglected Tropical Diseases (…

Newsroom

Why Global
Health R&D

Japan's Science and Pharmaceutical Capabilities for Global Health

Business
Model

World’s First Public-Private Partnership Fund for Global Health R&D

Investment
Opportunities

R&D Platforms and RFP Schedule

Investment to Date
since 2013

Total Investment

Total Invested
Partnerships

Total Product
Development Partners

Clinical Trials